Diffuse Pancreatic Carcinoma with Hepatic Metastases

Overview

Journal Case Rep Oncol Med

Publisher Wiley

Specialty Oncology

Date 2020 Nov 16

PMID 33194237

Citations 2

Authors

Hoang Quan Nguyen

Ngoc Trinh Thi Pham

Van Trung Hoang

Hoang Anh Thi Van

Chinh Huynh

Duc Thanh Hoang

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is one of the seven leading causes of cancer death worldwide. Diffuse pancreatic carcinoma is very rare and underreported in the literature. Many advances have been made in the diagnosis and management of pancreatic cancer. However, most pancreatic cancer cases are detected at the terminal or metastatic stages. Therefore, timely diagnosis and therapeutic management are desirable goals for this disease. Although the proliferation of pancreatic cancer has been reduced by intervention, more work is needed to treat and prevent the disease. The purpose of this article is to present a case of a 54-year-old male with pancreatic cancer and to review the epidemiology, diagnosis, management, and prevention of pancreatic tumors in general as well as pancreatic carcinoma in particular.

Citing Articles

Diffuse Type Pancreatic Ductal Adenocarcinoma: The Linitis Plastica Type of the Pancreas.

Radwan M, Darawsha B, Mansour S, Khuri S J Med Cases. 2024; 15(12):406-410.

PMID: 39610910 PMC: 11602175. DOI: 10.14740/jmc5062.

Diffuse-Type Pancreatic Ductal Adenocarcinoma Mimicking Autoimmune Pancreatitis.

Chow K, Hu S, Sikavi C, Bell M, Gisi B, Chiu R ACG Case Rep J. 2023; 10(6):e01070.

PMID: 37312756 PMC: 10259635. DOI: 10.14309/crj.0000000000001070.

References

Rawla P, Sunkara T, Gaduputi V . Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019; 10(1):10-27. PMC: 6396775. DOI: 10.14740/wjon1166. View

Choi Y, Byun J, Kim J, Kim M, Jang S, Ha H . Diffuse pancreatic ductal adenocarcinoma: characteristic imaging features. Eur J Radiol. 2007; 67(2):321-328. DOI: 10.1016/j.ejrad.2007.07.010. View

Danet I, Semelka R, Nagase L, Woosely J, Leonardou P, Armao D . Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging. 2003; 18(2):181-8. DOI: 10.1002/jmri.10337. View

Miller F, Rini N, Keppke A . MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol. 2006; 187(4):W365-74. DOI: 10.2214/AJR.05.0875. View

Lee E, Lee J . Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014; 20(24):7864-77. PMC: 4069314. DOI: 10.3748/wjg.v20.i24.7864. View

Tempero M, Arnoletti J, Behrman S, Ben-Josef E, Benson 3rd A, Casper E . Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012; 10(6):703-13. PMC: 3807091. DOI: 10.6004/jnccn.2012.0073. View

Comen E, Bowman R, Kleppe M . Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. Front Cell Dev Biol. 2018; 6:56. PMC: 6005853. DOI: 10.3389/fcell.2018.00056. View

Regel I, Mayerle J, Mahajan U . Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer. Cancers (Basel). 2020; 12(4). PMC: 7226595. DOI: 10.3390/cancers12041024. View

Lambert A, Schwarz L, Borbath I, Henry A, Van Laethem J, Malka D . An update on treatment options for pancreatic adenocarcinoma. Ther Adv Med Oncol. 2019; 11:1758835919875568. PMC: 6763942. DOI: 10.1177/1758835919875568. View

10.

Porcelli L, Iacobazzi R, Di Fonte R, Serrati S, Intini A, Solimando A . CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers (Basel). 2019; 11(3). PMC: 6468868. DOI: 10.3390/cancers11030330. View

11.

Miyoshi H, Kano M, Kobayashi S, Ito T, Masuda M, Mitsuyama T . Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis. Intern Med. 2019; 58(17):2523-2527. PMC: 6761344. DOI: 10.2169/internalmedicine.2689-19. View

12.

Ashida R, Tanaka S, Yamanaka H, Okagaki S, Nakao K, Fukuda J . The Role of Transabdominal Ultrasound in the Diagnosis of Early Stage Pancreatic Cancer: Review and Single-Center Experience. Diagnostics (Basel). 2018; 9(1). PMC: 6468797. DOI: 10.3390/diagnostics9010002. View

13.

Mostafa M, Erbarut-Seven I, Pehlivanoglu B, Adsay V . Pathologic classification of "pancreatic cancers": current concepts and challenges. Chin Clin Oncol. 2018; 6(6):59. DOI: 10.21037/cco.2017.12.01. View

14.

Yao W, Maitra A, Ying H . Recent insights into the biology of pancreatic cancer. EBioMedicine. 2020; 53:102655. PMC: 7118569. DOI: 10.1016/j.ebiom.2020.102655. View

15.

Kanji Z, Gallinger S . Diagnosis and management of pancreatic cancer. CMAJ. 2013; 185(14):1219-26. PMC: 3787168. DOI: 10.1503/cmaj.121368. View

16.

Vaz J, Ansari D, Sasor A, Andersson R . SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer. Pancreas. 2015; 44(7):1024-35. PMC: 4568900. DOI: 10.1097/MPA.0000000000000409. View

17.

Pelosi E, Castelli G, Testa U . Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Biomedicines. 2017; 5(4). PMC: 5744089. DOI: 10.3390/biomedicines5040065. View

18.

Yabar C, Winter J . Pancreatic Cancer: A Review. Gastroenterol Clin North Am. 2016; 45(3):429-45. DOI: 10.1016/j.gtc.2016.04.003. View

19.

Hasan S, Jacob R, Manne U, Paluri R . Advances in pancreatic cancer biomarkers. Oncol Rev. 2019; 13(1):410. PMC: 6478006. DOI: 10.4081/oncol.2019.410. View

20.

Tummala P, Junaidi O, Agarwal B . Imaging of pancreatic cancer: An overview. J Gastrointest Oncol. 2012; 2(3):168-74. PMC: 3397617. DOI: 10.3978/j.issn.2078-6891.2011.036. View